Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.85 USD | -0.68% | -6.85% | -11.63% |
05-10 | Piper Sandler Adjusts Price Target on TELA Bio to $10 From $12, Maintains Overweight Rating | MT |
05-09 | Earnings Flash (TELA) TELA BIO Posts Q1 Revenue $16.6M, vs. Street Est of $16.3M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.63% | 144M | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.12B | |
+2.64% | 50.65B | |
+6.58% | 43.11B | |
+2.18% | 41.3B | |
+21.98% | 31.6B | |
+15.77% | 25.03B | |
-5.81% | 24.16B |
- Stock Market
- Equities
- TELA Stock
- News TELA Bio, Inc.
- Tela Bio Posts Wider Q4 Net Loss, Higher Revenue; Warns of Potential Pandemic-Related Impact on FY'22 Outlook -- Shares Down After-Hours